According to to a 2023 study, nearly three-fourths of the adult population was overweight or obese. Obesity is a significant risk factor for developing type-2 diabetes, a chronic condition marked by excessive amounts of glucose sticking to hemoglobin when the body fails to break it down and deliver it as fuel to cells.

In their winter issue, Real Woman takes a look at how advancements in detection and treatment, including continuous glucose monitors and drugs like Ozempic and Wegovy, are changing how we manage and prevent this rampant disease.